Human and environmental health challenges for the next decade (20102020)

Critical Reviews in Toxicology

Volumn 40, Issue 10, 2010, Pages 893-911

  Bonnefoi, Marc S ^a   Belanger, Scott E ^b   Devlin, Dennis J ^c   Doerrer, Nancy G ^d   Embry, Michelle R ^d   Fukushima, Shoji ^e   Harpur, Ernest S ^f   Hines, Ronald N ^g   Holsapple, Michael P ^d   Kim, James H ^d   MacDonald, James S ^h   O'Lone, Raegan ^d   Pettit, Syril D ^d   Stevens, James L ⁱ   Takei, Ayako S ^j   Tinkle, Sally S ^k   Van Der Laan, Jan Willem ^l  

^a SANOFI   (France)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^d ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^e Japan Bioassay Research Center   (Japan)

^f Alnwick Research Centre   (United Kingdom)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h Chrysalis Pharma Consulting   (United States)

ⁱ ELI LILLY AND COMPANY   (United States)

^j ICaRuS Japan Limited   (Japan)

^k NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^l NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

Environmental health challenges; HESI; human health challenges; priority setting; risk assessment; scientific mapping; strategic planning; toxicology

Indexed keywords

COSMETIC; HLA ANTIGEN; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ANIMAL USE; ANIMAL WELFARE; BIOLOGICAL MONITORING; CANCER RISK; CARCINOGEN TESTING; CLIMATE CHANGE; COMMERCIAL PHENOMENA; DISEASE PREDISPOSITION; DNA MODIFICATION; ENVIRONMENTAL HEALTH; EPIGENETICS; EXPERIMENTAL ANIMAL; FINANCIAL MANAGEMENT; FOOD SAFETY; GENETIC POLYMORPHISM; GENOMICS; GOVERNMENT; GOVERNMENT REGULATION; HUMAN; INFLUENZA VIRUS A H1N1; INTERPERSONAL COMMUNICATION; JAPAN; LIFE CYCLE ASSESSMENT; NANOTECHNOLOGY; NATIONAL HEALTH ORGANIZATION; PANDEMIC INFLUENZA; PLURIPOTENT STEM CELL; POLICY; POLLUTANT; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SOCIOECONOMICS; UNITED STATES;

ACADEMIES AND INSTITUTES; ENVIRONMENTAL HEALTH; GOVERNMENT; HEALTH PLANNING GUIDELINES; HEALTH PRIORITIES; HUMANS; INDUSTRY; PUBLIC HEALTH; RISK ASSESSMENT; TOXICOLOGY;

EID: 77957984061     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.506640     Document Type: Review

References (21)

1. Bercu JP, Hofman WP, Lee C, Ness DK. (2008). Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance. Regul Toxicol Pharmacol 51:270-277.
2. Best Pharmaceuticals for Children Act of 2002. (2002). US Public Law No. 107-109. http://www.fda.gov/RegulatoryInformation/ Legislation/FederalFoo dDrugandCosmeticActFD C Act/ SignifcantAmendmentstotheFDCAct/ucm148011.htm. Accessed 22 March 2010.
3. Boobis A, Cohen S, Doerrer N, Galloway S, Haley P, Hard G, Hess F, MacDonald J, Tibault S, Wolf D, Wright J. (2009). A data-based assessment of alternative strategies for identifcation of potential human cancer hazards. Toxicol Pathol 37:714-732.
4. Chapin RE, Stedman DB. (2009). Endless possibilities: Stem cells and the vision for toxicology testing in the 21st century. Toxicol Sci 112:17-22.
5. Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, Fenner-Crisp P. (2004). Evaluating the human relevance of chemically-induced animal tumors. Toxicol Sci 78:181-186.
6. De Zwart D, Dyer SD, Posthuma L, Hawkins CP. (2006). Predictive models attribute efects on fsh assemblages to toxicity and habitat alteration. Ecol Appl 16:1295-1310.
7. European Commission (EC). (2007). Corrigendum to Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No. 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Ofcial Journal of the European Union. L136, 3-282.
8. Gatanaga H, Honda H, Oka S. (2008). Pharmacogenetic information derived from analysis of HLA alleles. Pharmacogenomics 9:207-214.
9. Hall W, Gartner C. (2009). Direct-to-consumer genome-wide scans: Astrologicogenomics or simple scams? Am J Bioethics 9:54-56.
10. Hartung T, Daston G. (2009). Are in vitro tests suitable for regulatory use? Toxicol Sci 111:233-237.
11. Hartung T, Rovida C. (2009). Chemical regulators have overreached. Nature 460:1080-1081.
12. Hines RN, Sargent D, Birnbaum LS, Brent RL, Doerrer NG, Cohen Hubal E, Juberg DR, Laurent C, Luebke R, Olejniczak K, Portier C, Slikker W. (2010). Approaches for assessing risks to sensitive populations: Lessons learned from evaluating risks in the pediatric population. Toxicol Sci 113:4-26.
13. Hubal EA. (2009). Biologically relevant exposure science for 21st century toxic-ity testing. Toxicol Sci 111:226-232.
14. International Standards Organization (ISO). (2006). Environmental Management\-Life Cycle Assessment\-Requirements and Guidelines, Edition 1. ISO.14044:2006. Geneva, Switzerland: ISO.
15. Kid-Safe Chemicals Act of 2008. (2008). S-3040, 110th US Congress. http:// www.govtrack.us/congress/bill.xpd?bill=s110-3040. Accessed 22 March 2010.
16. National Research Council (NRC). (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. National Academy of Sciences. Washington, DC: The National Academy Press.
17. Organisation for Economic Co-operation and Development (OECD). (1981). Mutual Acceptance of Data. Paris, France: OECD. http://www.oecd.org/ document/41/0,3343,en-2649-34365-1890473-1-1-1-1,00.html. Accessed 22 March 2010.
18. Russell WMS, Burch RL. (1959). The Principles of Humane Experimental Technique. Methuen, London: Universities Federation for Animal Welfare.
19. Satterfeld MB, Kolb CE, Peoples R, Adams GL, Schuster DS, Ramsey HC, Stechel E, Wood-Black F, Garant RJ, Abraham RJ. (2009). Overcoming nontechnical barriers to the implementation of sustainable solutions in industry. Environ Sci Technol 43:4221-4226.
20. Smith LL, Brent RL, Cohen SM, Doerrer NG, Goodman JI, Greim H, Holsapple MP, Lightfoot RM. (2008). Predicting future human and environmental health challenges: The Health and Environmental Sciences Institute's scientifc mapping exercise. Crit Rev Toxicol 38: 817-845.
21. Tueros I, Borja A, Larreta J, Rodriguez JG, Valencia V, Milan E. (2009). Integrating long-term water and sediment pollution data, in assessing chemical status within the European Water Framework Directive. Mar Pollut Bull 58:1389-1400.